Search clinical trials for: Rasagiline mesylate with Requip

Total 59 results

Teva Neuroscience, Inc.

Completed

A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

Parkinson's Disease
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study for Rasagiline Effect on Sleep Trial(REST)in Parkinson's Disease (PD)

Parkinson's Disease
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.

Parkinson's Disease

United States, Canada
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

Parkinson's Disease

United States
Teva Branded Pharmaceutical Products R&D, Inc.
H. Lundbeck A/S; Teva Neuroscience, Inc.

Completed

ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects

Parkinson's Disease

United States, Argentina, Canada, France, Germany, Hungary, Israel, Italy, Netherlands, Portugal, Romania, Spain, United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease (ADAGIO)

Parkinson's Disease
Universita di Verona
Azienda Ospedaliera Universitaria Integrata Verona

Unknown

Pain in Parkinson's Disease With Motor Fluctuations. (PAINinPD)

Parkinson Disease

Italy
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease

Parkinson's Disease
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline

Parkinson's Disease

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients

Parkinson's Disease

United States
Teva Branded Pharmaceutical Products R&D, Inc.
H. Lundbeck A/S

Completed

Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)

Multiple System Atrophy

United States, Austria, Canada, France, Germany, Hungary, Israel, Italy, Netherlands, Portugal, Spain, United Kingdom
Teva Neuroscience, Inc.

Completed

Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa

Parkinson's Disease
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease

Parkinson's Disease

United States
Fundació Institut de Recerca de l'Hospital de la...
Sociedad Española de Neumología y Cirugía Torácica; Universitat Autonoma de...

Completed

ATP Project (Asthma afTer Polypectomy) (ATP)

Asthma | Nasal Polyps

Spain
University of Malaya

Unknown

Air Polishing as an Adjunct in Non-surgical Periodontal Therapy

Periodontitis

Malaysia
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.

Parkinson's Disease
Cairo University

Not yet recruiting

Evaluation of Glass Ionomer With Advanced Glass Hybrid Technology Versus Resin Modified Glass Ionomer in Adult Patients With Carious Cervical Lesions After One Year

Dental Caries Class v
University of Sao Paulo

Completed

Cost-efficacy of Atraumatic Restorations (ART) Using Different Encapsulated Glass Ionomer Cement

Dental Caries

Brazil
University of Sao Paulo

Completed

Giomer vs Glass Ionomer Cement for ART Occlusoproximal Restorations: a Randomized Clinical Trial

Dental Caries

Brazil
Guangzhou Institute of Respiratory Disease
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Efficacy and Safety of Apatinib as Third-line Therapy for Primary Pulmonary Lymphoepithelioid Carcinoma (Spark-AL003)

Lung Carcinoma

China
Hubei Cancer Hospital

Enrolling by invitation

Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC

NSCLC

China
Changzhou Cancer Hospital of Soochow University

Completed

An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer (EASE)

Non-small Cell Lung Cancer

China
University Hospital Center of Martinique

Completed

Comparison of Two Rhythm of Administration of Prostaglandin Gel for Induction of Labor (GELFREQ)

Labor Complication | Cervix

Martinique
Henan Cancer Hospital

Recruiting

Camrelizumab Combined With Apatinib Mesylate

Solid Tumor

China
Memorial Sloan Kettering Cancer Center

Terminated

Cardiac Monitoring of Post-Operative Cancer Patients Experiencing Atrial Fibrillation

Fibrillation | Post-Operative Cancer Patients Experiencing Atrial

United States
Fox Chase Cancer Center
Novartis

Terminated

Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Metastatic Disease | GIST

United States
Tianjin Medical University Second Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Treatment of Carrying TP53 Harmful Mutations

Advanced Cancer

China
Inova Health Care Services
Novartis Pharmaceuticals

Completed

New Individualized Therapy Trial for Metastatic Colorectal Cancer (NITMEC)

Colorectal Cancer | Colorectal Neoplasm

United States
Viracta Therapeutics, Inc.

Recruiting

A Mass Balance Study of [14C]-Nanatinostat and Relative Bioavailability Study of Nanatinostat in Patients With Advanced Cancers

Advanced Cancer

Spain
Sun Yat-sen University

Not yet recruiting

Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Bristol-Myers Squibb

Withdrawn

Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase

Myeloid Leukemia, Chronic, Chronic-Phase

United States
Beijing Friendship Hospital

Completed

Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer

Gastric Cancer
Yonsei University

Terminated

Evaluation of the Effect of Gabexate Mesilate in the Hepatocyte Protection After Liver Resection

Liver Disease

Korea, Republic of
National Cancer Institute (NCI)

Active, not recruiting

Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer

Metastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Recurrent Bladder Urothelial Carcinoma | Recurrent Renal Pelvis Urothelial Carcinoma | Recurrent Ureter Urothelial Carcinoma and other conditions

United States
Peking University Cancer Hospital & Institute

Unknown

A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced Melanoma

Advanced Melanoma

China
Suzhou Genhouse Bio Co., Ltd.

Recruiting

A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC

Non-Small Cell Lung Cancer With EGFR Mutation

China
Cairo University

Unknown

Clinical Evaluation of Glass Ionomer With Glass Hybrid Technology Versus Conventional High Viscosity Glass Ionomer in Class I Cavities of High Caries Risk Patients

Class I Cavities in High Caries Risk

Egypt
Cairo University

Recruiting

Clinical Evaluation of SDF Combined With KI Versus SDF in Management of Class I Carious Lesions

Carious Lesion

Egypt
Peking University People's Hospital

Completed

A Comparative Study of Rimazolam and Propofol Combined With Etomidate in Gastroenteroscopy in Elderly Patients

Gastrointestinal Endoscopy | Elderly Patients | Remimazolam Besylate | Etomidate Combined With Propofol

China
Sheba Medical Center

Unknown

Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 Virus (COSTA)

COVID - 19

Israel
Fudan University

Recruiting

Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer (BCTOP-T-M01)

Triple-Negative Breast Cancer

China
University of Sao Paulo

Completed

Primary Molars Restorations With Encapsulated or Hand-Mixed Glass Ionomer: Clinical Trial

Dental Caries

Brazil
Lindner Center of HOPE
Shire; University of Cincinnati

Terminated

Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression

Depression | Bipolar

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

Effect of Itraconazole on the Pharmacokinetics of Apatinib

Neoplasms

China
Roswell Park Cancer Institute
Pfizer

Recruiting

Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer

Advanced Malignant Solid Neoplasm | Metastatic Colorectal Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Clinical Stage III... and other conditions

United States
Yonsei University
SK Chemicals Co., Ltd.

Completed

The Effect of Nafamostat Mesilate in Prolonging Filter Patency With Patients on Continuous Renal Replacement Therapy

Acute Kidney Injury

Korea, Republic of
Masonic Cancer Center, University of Minnesota

Terminated

Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia

Lymphoma | Leukemia

United States
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University; McMaster University

Completed

Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma

Gastric Cancer

United States
National Cancer Institute (NCI)

Completed

Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma

Stage IV Skin Melanoma | Recurrent Melanoma | Stage III Skin Melanoma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Withdrawn

Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation

Recurrent Acute Myeloid Leukemia

United States

Search clinical trials for: Rasagiline mesylate with Requip

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations